Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;61(7):965-970.
doi: 10.2967/jnumed.120.245381. Epub 2020 Jun 1.

Molecular Imaging of Cardiac Amyloidosis

Affiliations
Review

Molecular Imaging of Cardiac Amyloidosis

Ahmad Masri et al. J Nucl Med. 2020 Jul.

Abstract

Transthyretin and light-chain amyloidosis are the 2 main causes of cardiac amyloidosis. Recent developments in molecular imaging have transformed our ability to diagnose transthyretin cardiac amyloidosis noninvasively and unmasked a hitherto unrecognized prevalence of the disease. This review summarizes the current and evolving imaging approaches, their molecular structural basis, and the gaps in imaging capabilities that have arisen as a result of parallel developments in pharmacotherapy delivering the first effective treatment options for this condition.

Keywords: ATTR; SPECT; bone-seeking tracers; cardiac amyloidosis; molecular imaging.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Molecular mechanism of amyloidosis and imaging characteristics illustrated for ATTR amyloidosis and AL amyloidosis. Echocardiography, CMR, and thioflavin-analog PET tracers detect both types, whereas 99mTc-labeled bone tracers (BST) are avidly taken up only by ATTR amyloidosis. Notably, hereditary amyloidosis resulting from some mutations result in type B amyloid fibrils, which are less avid for BST. On the other hand, prior reports suggest that some patients with AL may show BST uptake. Differentiation of ATTR from AL amyloidosis is a critical step in evaluation of patients with suspected CA. Wt = wild-type.
FIGURE 2.
FIGURE 2.
(Left) 99mTc-pyrophosphate planar scan showing avid myocardial tracer uptake (Perugini grade 3, myocardial uptake greater than rib). (Right) Cardiac SPECT showing diffuse myocardial tracer uptake in short-axis images (top row), vertical-long axis images (middle row), and horizontal long-axis (bottom row). This scan is diagnostic of ATTR cardiomyopathy if serum and urine studies for AL amyloidosis are negative.
FIGURE 3.
FIGURE 3.
(Left) 99mTc-pyrophosphate planar scan showing mild myocardial tracer uptake (Perugini grade 1, myocardial uptake of tracer less than rib). (Right) Chest SPECT images showing tracer in left ventricular cavity as seen best in coronal views (top 2 rows and magnified image) compared with sagittal view (third row from top) or transaxial view (bottom row), illustrating value of SPECT for differentiating blood pool from myocardial activity. In cases without myocardial tracer uptake, it is easier to perform chest reconstruction than cardiac reconstruction.
FIGURE 4.
FIGURE 4.
Congo red, thioflavin T, and its analogs 11C-PIB, 18F-florbetapir, and 18F-florbetapen bind to both ATTR and AL amyloid fibrils. 99mTc bone-seeking tracers show avid uptake in ATTR, possibly related to microcalcification. Increased uptake of 18F-FDG in AL is attributed to inflammation and macrophage infiltration. Serum amyloid P component (SAP) in 123I-SAP binds to both ATTR and AL fibrils. 11-1F4 is monoclonal antibody against immunoglobulin ALs.

References

    1. Orphan drug regulations: regulatory history. U.S. Food and Drug Administration website. http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditio.... Revised February 28, 2018. Accessed June 5, 2020.
    1. Quock TP, Yan T, Chang E, Guthrie S, Broder MS. Epidemiology of AL amyloidosis: a real-world study using US claims data. Blood Adv. 2018;2:1046–1053. - PMC - PubMed
    1. Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol. 2015;24:343–350. - PubMed
    1. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583–596. - PubMed
    1. Shi J, Guan J, Jiang B, et al. . Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38α MAPK pathway. Proc Natl Acad Sci USA. 2010;107:4188–4193. - PMC - PubMed

MeSH terms